Position in AZN
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$46,603,480
New position
Shares Held
236,302
first reported quarter
Ownership
0.015%
of shares outstanding
% of Portfolio
0.59%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $451,805,560 across 10 Drug Manufacturers - General names. AZN ranks #4 (10.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
127,233 | $117,025,096 | |
| 2 | JNJ |
Johnson & Johnson
|
397,877 | $97,257,053 | |
| 3 | ABBV |
AbbVie Inc.
|
283,811 | $61,726,054 | |
| 4 | AZN |
Astrazeneca PLC
This page
|
236,302 | $46,603,480 | |
| 5 | MRK |
Merck & Co., Inc.
|
364,485 | $43,843,900 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
222,601 | $31,023,901 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
332,662 | $20,175,950 | |
| 8 | AMGN |
Amgen Inc
|
50,366 | $17,721,277 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $46,603,480 | 236,302 | Shares | Sole | 2026-05-08 | |
| No filing history on record for this holder in this stock. | ||||||